Oracle's AI Bet: Is the Funding Overhang Already Priced In?

The prevailing market narrative around Oracle is one of sharp risk discounting. Since its peak in September, the stock has lost more than half its value, trading now in a range of $168–170. This derating has been brutal, with the share price tumbling roughly 34% since November 11, 2025. The financial metrics tell a clear story of a valuation collapse: the stock's P/E multiple has halved from 53.5 to 29.1 over that same period. In other words, the market is pricing Oracle not for its current profitability, but for the significant capital and potential dilution required to execute its AI strategy.

This sentiment crystallized recently with a notable downgrade. On February 9, Melius Research downgraded the stock from Buy to Hold, highlighting the core investor anxiety. The firm's analyst, Ben Reitzes, flagged weak cash generation and AI monetization uncertainty as key concerns. His assessment was stark: given the company's trajectory, Oracle should be valued "more akin to an infrastructure company vs. a software company". This shift in perspective underscores the market's fear that the aggressive infrastructure investments will absorb cash flow for years, with one analyst questioning "What should a stock sell for with no free cash flow until the 2030s?"

Yet, a critical nuance exists. Despite this downgrade and the steep price decline, the stock has shown resilience in the face of negative headlines. It traded up on the day of the Melius note, suggesting that some of the worst-case scenarios may already be reflected in the share price. The market appears to be discounting the funding risk and leverage concerns, not because the operating story is broken, but because the valuation has already been reset to account for them. The question now is whether this reset is too severe, or if it has priced in the full extent of the capital-intensive journey ahead.

The Operating Reality: Strong Growth Amidst the Noise

While the market fixates on the funding overhang, Oracle's underlying business is demonstrating robust health. The operating story has not collapsed; it is advancing on multiple fronts, creating a stark contrast with the sentiment-driven stock price. For all the talk of capital intensity, the company is generating significant revenue and profit growth, providing a tangible foundation for its ambitious AI investments.

The top-line momentum is clear. Last quarter, Oracle reported total revenue of $16.1 billion, representing a 14% year-over-year increase in USD and a 13% rise on a constant-currency basis. More importantly, its fiscal 2026 revenue guidance sits at $67 billion, a target that implies continued strong execution. This growth is powered almost entirely by the cloud, which is the true growth spine. Cloud services revenue surged 34% in USD last quarter, with the infrastructure segment (OCI) reporting an impressive 68% year-over-year jump. This acceleration in OCI, which grew close to 70% last quarter, signals that the company's core cloud platform is gaining significant traction with enterprise customers.

The most telling metric, however, is the visibility into future revenue. Oracle's Remaining Performance Obligations (RPO) soared 438% year-over-year to $523 billion. This massive increase, which includes a $68 billion sequential rise, is a powerful indicator of contracted demand. It suggests that a vast amount of revenue is already locked in, providing a long-term runway that buffers against near-term volatility. This level of contracted future income is a critical asset when funding a multi-year AI build-out.

Profitability is also accelerating. Non-GAAP earnings per share last quarter came in at $2.26, beating consensus by a wide margin. The company's GAAP earnings per share jumped 91% to $2.10, driven by strong operating income and a significant one-time gain from the sale of its Ampere chip stake. This combination of top-line growth, cloud acceleration, and rising profitability creates a powerful counter-narrative to the funding concerns. The market is discounting the risk, but the operating reality shows a company scaling rapidly and generating substantial cash flow to support that scale.

The bottom line is that Oracle's current valuation is being set against a backdrop of strong fundamentals. The stock's derating has been severe, but the underlying business performance-evidenced by the 13-14% revenue growth, mid-30s cloud expansion, and the staggering RPO increase-suggests the company is not in distress. The consensus view is one of a high-quality, high-growth story facing a funding hurdle. The key investment question now is whether the market has already priced in that hurdle to the point of perfection, leaving little room for error.

The Funding Overhang: A Necessary Cost or a Value Drain?

The scale of Oracle's planned financing is staggering, but its purpose is clear: to fund the build-out of capacity for contracted demand. The company has announced a $45 to $50 billion gross cash raise for calendar 2026, to be achieved through a balanced mix of debt and equity. On the equity side, this includes a newly authorized at-the-market program of up to $20 billion, alongside other issuances. The debt portion will be a single, one-time bond offering early in the year. Management frames this not as a crisis, but as a necessary investment to meet the needs of major cloud customers like AMD, Meta, and NVIDIA.

This plan directly confronts the market's primary fear. Melius Research's downgrade highlighted that "value may be absorbed by debt and new stock issuances for a while", warning of a prolonged period without strong free cash flow. The analyst's point is that such a massive capital raise, especially one involving equity issuance at prevailing market prices, carries a clear dilution risk. It suggests the company's enterprise value could be eroded by the sheer act of funding its growth, a scenario that would weigh on the stock for years.

Management's counter-argument is that this capex is justified by existing demand. The company's Remaining Performance Obligations (RPO) soared 438% year-over-year to $523 billion. Oracle's logic is that the new RPO is tied to capacity that already exists or is coming online soon, meaning the aggressive capital expenditure is a direct response to locked-in revenue, not speculative spending. In this view, the financing is a cost of doing business at scale, not a sign of financial distress.

The tension here is classic "expectations vs. reality." The market sentiment, as captured by the Melius downgrade, is one of deep skepticism about the value of this investment. It fears the dilution and debt will sap value for an extended period. Yet, the operating reality-massive contracted demand and strong growth-provides a foundation for the plan. The key investment question is whether the stock's current price of around $168 already reflects the worst-case dilution scenario. If so, the risk/reward may be more favorable than the consensus view suggests.

Valuation and Catalysts: What Could Close the Expectations Gap?

The current setup presents a classic risk/reward asymmetry. The stock's P/E multiple has collapsed from 53.5 to 29.1 since November, a discount that reflects severe skepticism over the funding plan and AI monetization. Yet, the operating fundamentals-strong revenue growth, accelerating cloud expansion, and staggering contracted demand-suggest the company is not in distress. The market is pricing for perfection in execution, leaving little room for error. The key question is whether this reset is too severe or if it has already baked in the worst-case dilution and debt scenario.

The primary catalyst for a re-rating is the flawless execution of the $45 to $50 billion financing plan. The market will scrutinize two critical elements: the cost of equity issuance and the pace of OCI growth. If Oracle can raise capital without triggering a catastrophic dilution event-perhaps by favoring the debt component or timing equity sales wisely-and if OCI continues its close to 70% year-over-year growth, it will validate the thesis that the capex is justified by contracted demand. Positive news on this front could quickly close the expectations gap, as the stock's recent resilience to negative headlines suggests much of the funding risk is already priced in.

Conversely, the primary risk is a failure of AI workload demand to materialize as anticipated. If the massive contracted RPO does not translate into sustained, high-margin revenue, Oracle will be left with a significantly higher debt load and a more diluted equity base, all while facing the same AI infrastructure doubts that initially spooked the market. This scenario would confirm the Melius Research view that the company should be valued as an infrastructure play, not a software one. The stock's sharp decline from its peak, despite solid margins, shows how quickly sentiment can turn if the growth narrative falters.

In practice, the path forward hinges on visibility. The $523 billion in Remaining Performance Obligations provides a long-term runway, but the market needs quarterly proof points. Sustained OCI growth and disciplined capital allocation will be the key metrics. For now, the valuation suggests extreme caution is priced in. The risk/reward leans toward the upside if execution is good, but the downside from a demand miss is severe. The catalyst is clear: watch the financing details and the OCI growth trajectory.